Lowell E. Sears serves as Chairman, Chief Executive Officer, and Chief Investment Officer of Sears Capital Management. See sector focus and contact routes.
Lowell E. Sears serves as Chairman, Chief Executive Officer, and Chief Investment Officer of Sears Capital Management, a venture firm he has led since 1994 after previously holding senior financial roles at Amgen and Atlantic Richfield. His investment thesis focuses exclusively on the life sciences sector, specifically targeting pharmaceuticals and medical devices at the seed and early stages within the United States. The firm provides seed capital and early-stage financing for startups, though specific check sizes and whether Sears typically leads or follows deals are not publicly detailed. Notable portfolio companies include Cellerant Therapeutics, where Sears serves on the board of directors, and CoCensys Inc., a neurological and psychiatric disorder developer he also joined as a director. Over his career, Sears has helped found and fund more than forty life science companies, reflecting deep operational experience in the industry. While he is an active participant in pharmaceutical and medical device industries since 1979, there is no publicly available record of distinctive public writing or a unique stated point of view beyond his firm’s life sciences
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cupertino.
Investors like Lowell E. Sears · Full investor directory · Investor access · Company funding database